CD79A and influenza: When formalin-inactivated IIV was intranasally administered, mice were protected from heterologous influenza strains despite the lack of neutralizing activity of mucosal IgA antibodies, suggesting that non-neutralizing IgA antibodies may be responsible for cross-protection [79].